APOTHEEK DEVRIESE: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
What changed
APOTHEEK DEVRIESE
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€83,394
2024 · €110,810-€27,416
Equity
€3.6m
2024 · €3.5m+€83,394
Cash
€132,578
2024 · €112,307+€20,272
Balance sheet total
€3.8m
2024 · €4.1m-€260,702
Largest movements
Assets
- Receivables within one year -€268,290
down €268,290 (-11.8%), from €2.3m to €2.0m
of which Other amounts receivable: -€289,333
Equity and liabilities
- Current portion of long-term debt -€324,804
down €324,804 (-96.0%), from €338,513 to €13,709
- Reserves +€83,394
up €83,394 (+3.7%), from €2.3m to €2.4m
of which Distributable reserves: +€83,394
Income statement
- Staff costs +€69,341
up €69,341 (+53.8%), from €128,929 to €198,270
- Gross operating margin +€44,108
up €44,108 (+17.5%), from €251,762 to €295,870
- Financial income -€23,695
down €23,695 (-23.0%), from €103,212 to €79,518
- Financial charges -€22,403
down €22,403 (-53.5%), from €41,861 to €19,458
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Result 2024
€110,810
Gross operating margin
+€44,108
Staff costs
-€69,341
Depreciation
-€1,926
Other operating charges
+€55
Financial income
-€23,695
Financial charges
+€22,403
Taxes
+€980
Result 2025
€83,394
raises the resultlowers the result
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
From operations
+€376,523
Investment
-€17,739
Financing
-€338,513
Cash 2024
€112,307
From operations (derived)
+€376,523
Net result for the year
+€83,394
Depreciation
+€39,527
Stocks and contracts
-€6,648
Receivables within one year
+€268,290
Deferred charges and accrued income
-€2,457
Trade debts
+€3,766
Tax, wage and social debts
+€9,135
Other debts
-€18,384
Accrued charges and deferred income
-€100
Investment (derived)
-€17,739
Investment in fixed assets (net)
-€5,606
Current investments
-€12,132
Financing
-€338,513
Debts after one year
-€13,709
Current portion of long-term debt
-€324,804
Cash 2025
€132,578
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €4,097,787 | €3,837,086 | -€260,702 | -6.4% |
| Fixed assets | 21/28 | €603,018 | €569,097 | -€33,921 | -5.6% |
| Tangible fixed assets | 22/27 | €563,143 | €529,222 | -€33,921 | -6.0% |
| Land and buildings | 22 | €260,515 | €249,403 | -€11,112 | -4.3% |
| Plant, machinery and equipment | 23 | €294,348 | €273,778 | -€20,569 | -7.0% |
| Furniture and vehicles | 24 | €8,279 | €6,040 | -€2,239 | -27.0% |
| Financial fixed assets | 28 | €39,875 | €39,875 | = | 0.0% |
| Current assets | 29/58 | €3,494,770 | €3,267,989 | -€226,781 | -6.5% |
| Stocks and contracts in progress | 3 | €136,041 | €142,689 | +€6,648 | +4.9% |
| Stocks | 30/36 | €136,041 | €142,689 | +€6,648 | +4.9% |
| Amounts receivable within one year | 40/41 | €2,281,908 | €2,013,619 | -€268,290 | -11.8% |
| Trade receivables | 40 | €125,713 | €146,756 | +€21,043 | +16.7% |
| Other amounts receivable | 41 | €2,156,196 | €1,866,863 | -€289,333 | -13.4% |
| Current investments | 50/53 | €963,500 | €975,632 | +€12,132 | +1.3% |
| Cash at bank and in hand | 54/58 | €112,307 | €132,578 | +€20,272 | +18.1% |
| Deferred charges and accrued income | 490/1 | €1,013 | €3,470 | +€2,457 | +243% |
| Total equity and liabilities | 10/49 | €4,097,787 | €3,837,086 | -€260,702 | -6.4% |
| Equity | 10/15 | €3,494,683 | €3,578,077 | +€83,394 | +2.4% |
| Contributions | 10/11 | €225,300 | €225,300 | = | 0.0% |
| Reserves | 13 | €2,269,383 | €2,352,777 | +€83,394 | +3.7% |
| Non-distributable reserves | 130/1 | €22,530 | €22,530 | = | 0.0% |
| Reserves not available under the articles | 1311 | €22,530 | €22,530 | = | 0.0% |
| Distributable reserves | 133 | €2,246,853 | €2,330,247 | +€83,394 | +3.7% |
| Profit (loss) carried forward | 14 | €1,000,000 | €1,000,000 | = | 0.0% |
| Amounts payable | 17/49 | €603,104 | €259,009 | -€344,095 | -57.1% |
| Amounts payable after more than one year | 17 | €24,121 | €10,412 | -€13,709 | -56.8% |
| Financial debts | 170/4 | €24,121 | €10,412 | -€13,709 | -56.8% |
| Amounts payable within one year | 42/48 | €576,288 | €246,002 | -€330,286 | -57.3% |
| Current portion of amounts payable after more than one year | 42 | €338,513 | €13,709 | -€324,804 | -96.0% |
| Trade debts | 44 | €154,044 | €157,810 | +€3,766 | +2.4% |
| Suppliers | 440/4 | €154,044 | €157,810 | +€3,766 | +2.4% |
| Taxes, remuneration and social security | 45 | €27,750 | €36,885 | +€9,135 | +32.9% |
| Taxes | 450/3 | €0 | €980 | +€980 | +9,802,000% |
| Remuneration and social security | 454/9 | €27,750 | €35,905 | +€8,155 | +29.4% |
| Other amounts payable | 47/48 | €55,982 | €37,598 | -€18,384 | -32.8% |
| Accrued charges and deferred income | 492/3 | €2,695 | €2,595 | -€100 | -3.7% |
| Remuneration, social security and pensions | 62 | €128,929 | €198,270 | +€69,341 | +53.8% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €37,601 | €39,527 | +€1,926 | +5.1% |
| Other operating charges | 640/8 | €5,015 | €4,960 | -€55 | -1.1% |
| Gross operating margin | 9900 | €251,762 | €295,870 | +€44,108 | +17.5% |
| Operating profit (loss) | 9901 | €80,217 | €53,113 | -€27,105 | -33.8% |
| Financial income | 75/76B | €103,212 | €79,518 | -€23,695 | -23.0% |
| Recurring financial income | 75 | €103,212 | €79,518 | -€23,695 | -23.0% |
| Financial charges | 65/66B | €41,861 | €19,458 | -€22,403 | -53.5% |
| Recurring financial charges | 65 | €41,861 | €19,458 | -€22,403 | -53.5% |
| Profit (loss) for the period before taxes | 9903 | €141,568 | €113,172 | -€28,396 | -20.1% |
| Income taxes | 67/77 | €30,759 | €29,778 | -€980 | -3.2% |
| Profit (loss) for the period | 9904 | €110,810 | €83,394 | -€27,416 | -24.7% |
| Profit (loss) for the period to be appropriated | 9905 | €110,810 | €83,394 | -€27,416 | -24.7% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 14 October 2026 via checked.be.